Japanese Journal of Antibiotics 1992-10-01

[A clinical study of combined therapy of aspoxicillin and ceftazidime on intractable respiratory infections].

K Yamaki, R Suzuki, F Taki, K Takagi, T Satake, K Mizuno, K Baba, H Aihara, M Mori, K Yamada

文献索引:Jpn. J. Antibiot. 45(10) , 1282-94, (1992)

全文:HTML全文

摘要

Both aspoxicillin (ASPC) and ceftazidime (CAZ) were administered together to 55 patients with intractable respiratory tract infections. ASPC and CAZ were administered at daily doses of 4 g and 2 to 4 g, respectively. Clinical effects were excellent in 11 cases, good in 33, fair in 7 and poor in 4, thus the efficacy rate was 80.0%. Bacteriologically, identified organisms were eradicated in 14 cases out of 21, decreased in 3, exchanged in 2 and unchanged in 2. The eradication rate was 76.2%. As a side effect, diarrhea was found in only one case, and abnormal laboratory test values were observed in 4 cases. However, these adverse reactions were not severe, therefore it was possible to continue the chemotherapy. These results indicate that the combination antimicrobial chemotherapy of ASPC and CAZ is effective against intractable respiratory tract infections.


相关化合物

  • 阿扑西林

相关文献:

[In vitro study on efficacy of combination use of aspoxicillin and beta-lactam preparations (ceftazidime, cefmetazole and aztreonam) against bacteria isolated from abdominal infections].

1992-07-01

[Jpn. J. Antibiot. 45(7) , 763-73, (1992)]

Separation and determination of aspoxicillin in human plasma by micellar electrokinetic chromatography with direct sample injection.

[J. Chromatogr. A. 515 , 245-55, (1990)]

Antimicrobial susceptibility of Pasteurella multocida isolated from cattle and pigs.

2001-09-01

[J. Vet. Med. B. Infect. Dis. Vet. Public Health 48(7) , 555-60, (2001)]

Activity of sub-minimal inhibitory concentrations of aspoxicillin in prolonging the postantibiotic effect against Staphylococcus aureus.

1990-07-01

[J. Antimicrob. Chemother. 26(1) , 29-38, (1990)]

Aspoxicillin versus piperacillin in severe abdominal infections--a comparative phase III study.

1994-11-01

[J. Antimicrob. Chemother. 34(5) , 813-7, (1994)]

更多文献...